{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:59:23Z","timestamp":1789567163770,"version":"build-2803163510"},"reference-count":16,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vasc Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>\n                    Patients with chronic kidney disease may develop new or more severe anemia when treated with antiplatelet agents due to blood loss in conjunction with impaired erythropoiesis. Because anemia independently predicts limb amputation and mortality among patients with peripheral artery disease (PAD), we evaluated the relationship between estimated glomerular filtration rate (eGFR) and hemoglobin (Hb) levels in the EUCLID trial in which patients with symptomatic PAD were randomized to ticagrelor or clopidogrel. At baseline, 9025, 1870, and 1000 patients had eGFR \u2a7e 60, 45\u201359, and &lt; 45 mL\/min\/1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    , respectively. The mean fall in Hb during the trial was 0.46 \u00b1 1.68 g\/dL and did not differ by baseline eGFR category, although Hb fall \u2a7e 10% was more frequent among patients with lower eGFR ( p for trend &lt; 0.0001). On-study treatment with iron, erythropoiesis-stimulating agents, and\/or red blood cell transfusion was reported for 479 (5.3%), 165 (8.8%), and 129 (12.9%) patients in the three eGFR categories, respectively ( p for trend &lt; 0.0001). After adjustment for baseline and post-randomization effects, those not receiving anemia treatment had a smaller reduction in Hb from baseline than those receiving anemia treatment ( p &lt; 0.0001). Other determinants of Hb reduction included absence of on-study myocardial infarction, coronary or peripheral revascularization, residence outside North America, male sex, and baseline eGFR. We conclude that among patients with PAD treated with P2Y\n                    <jats:sub>12<\/jats:sub>\n                    inhibitors, lower baseline eGFR was associated with a greater reduction in Hb. ClinicalTrials.gov Identifier: NCT01732822\n                  <\/jats:p>","DOI":"10.1177\/1358863x211017641","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T21:15:38Z","timestamp":1622754938000},"page":"608-612","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y\n                    <sub>12<\/sub>\n                    inhibitors: Insights from the EUCLID trial"],"prefix":"10.1177","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3413-7836","authenticated-orcid":false,"given":"Judith","family":"Hsia","sequence":"first","affiliation":[{"name":"CPC Clinical Research, Aurora, CO, USA"},{"name":"Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah T","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"CPC Clinical Research, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W","family":"Hopley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, Hanover, NH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Department of Angiology, Inselspital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Berger","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Surgery, New York University School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry R","family":"Fowkes","sequence":"additional","affiliation":[{"name":"Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Schuyler","family":"Jones","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W","family":"Mahaffey","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-7132","authenticated-orcid":false,"given":"Lars","family":"Norgren","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, \u00d6rebro University Hospital, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R","family":"Patel","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-4765","authenticated-orcid":false,"given":"Frank","family":"Rockhold","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juuso","family":"Blomster","sequence":"additional","affiliation":[{"name":"AstraZeneca LP, Gothenburg, Sweden; Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G","family":"Katona","sequence":"additional","affiliation":[{"name":"AstraZeneca LP, Gothenburg, Sweden; Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Hiatt","sequence":"additional","affiliation":[{"name":"CPC Clinical Research, Aurora, CO, USA"},{"name":"Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P","family":"Bonaca","sequence":"additional","affiliation":[{"name":"CPC Clinical Research, Aurora, CO, USA"},{"name":"Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"bibr1-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"bibr2-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2014.04.005"},{"key":"bibr3-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.05.024"},{"key":"bibr4-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.01.018"},{"key":"bibr5-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19864172"},{"key":"bibr6-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611688"},{"key":"bibr7-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"bibr8-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.11.007"},{"key":"bibr9-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv584"},{"key":"bibr10-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008069"},{"key":"bibr11-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S39351"},{"key":"bibr12-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.05.058"},{"key":"bibr13-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.03.002"},{"key":"bibr14-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.228874"},{"key":"bibr15-1358863X211017641","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000034"},{"key":"bibr16-1358863X211017641","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","journal-title":"Kidney Int Suppl"}],"container-title":["Vascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X211017641","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1358863X211017641","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1358863X211017641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:31:59Z","timestamp":1777692719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1358863X211017641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1177\/1358863X211017641"],"URL":"https:\/\/doi.org\/10.1177\/1358863x211017641","relation":{},"ISSN":["1358-863X","1477-0377"],"issn-type":[{"value":"1358-863X","type":"print"},{"value":"1477-0377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]}}}